Status:

RECRUITING

Prodromal Markers in Recurrent Dream Enactment Behaviors Without REM Sleep Without Atonia

Lead Sponsor:

Chinese University of Hong Kong

Conditions:

REM Sleep Behavior Disorder

Eligibility:

All Genders

45-65 years

Brief Summary

REM sleep behavior disorder is a novel and distinct parasomnia characterized by recurrent dream enactment behaviors (DEBs) and REM sleep without atonia (RSWA) during polysomnographic assessment, with ...

Detailed Description

This proposed study is a case-control study, which aims to determine whether recurrent DEBs but without sufficient RSWA represents an early stage of α-synucleinopathy. The investigators will recruit 6...

Eligibility Criteria

Inclusion

  • Age between 45 and 65 years old
  • RBDQ-HK behavior factor greater \> 8
  • Recurrent DEBs by interview and/or video analysis
  • Absence of sufficient RSWA

Exclusion

  • Age- and sex- matched with cases
  • RBDQ-HK behavior factor \< 8
  • No DEBs by either interview or video analysis
  • Absence of sufficient RSWA

Key Trial Info

Start Date :

January 3 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 30 2024

Estimated Enrollment :

102 Patients enrolled

Trial Details

Trial ID

NCT05353881

Start Date

January 3 2022

End Date

June 30 2024

Last Update

April 19 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shatin Hospital

Shatin, Hong Kong